Aldehyde dehydrogenases: From eye crystallins to metabolic disease and cancer stem cells

Chemico-Biological Interactions

Volumn 202, Issue 1-3, 2013, Pages 2-10

  Vasiliou, Vasilis ^a   Thompson, David C ^a   Smith, Clay ^b   Fujita, Mayumi ^b   Chen, Ying ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Aldehyde dehydrogenase; Crystallin; Function; Gene superfamily; Metabolic disease; Stem cell

Indexed keywords

4 AMINOBUTYRALDEHYDE; 4 GUANIDINOBUTYRALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 10A1; ALDEHYDE DEHYDROGENASE 18A1; ALDEHYDE DEHYDROGENASE 1A1; ALDEHYDE DEHYDROGENASE 1A2; ALDEHYDE DEHYDROGENASE 1A3; ALDEHYDE DEHYDROGENASE 1L1; ALDEHYDE DEHYDROGENASE 3A1; ALDEHYDE DEHYDROGENASE 4A1; ALDEHYDE DEHYDROGENASE 5A1; ALDEHYDE DEHYDROGENASE 6A1; ALDEHYDE DEHYDROGENASE 7A1; ALDEHYDE DEHYDROGENASE 8A1; ALDEHYDE DEHYDROGENASE 9A1; ALDEHYDE DEHYDROGENASE ISOENZYME 2; AMINOBUTYRALDEHYDE DEHYDROGENASE; BETAINE ALDEHYDE DEHYDROGENASE; CRYSTALLIN; OXIDOREDUCTASE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

CANCER STEM CELL; CONFERENCE PAPER; DNA POLYMORPHISM; ENZYME ACTIVITY; EYE; GENE MUTATION; GENETIC ASSOCIATION; HEMATOPOIETIC STEM CELL; HUMAN; METABOLIC DISORDER; NOMENCLATURE; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ALDEHYDE DEHYDROGENASE; ANIMALS; CRYSTALLINS; HUMANS; LENS, CRYSTALLINE; METABOLIC DISEASES; NEOPLASTIC STEM CELLS;

EUKARYOTA;

EID: 84875211255     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2012.10.026     Document Type: Conference Paper

References (130)

1. S.A. Marchitti, C. Brocker, D. Stagos, and V. Vasiliou Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily Expert Opin. Drug Metab. Toxicol. 4 2008 697 720
2. D. Stagos, Y. Chen, M. Cantore, J.V. Jester, and V. Vasiliou Corneal aldehyde dehydrogenases: multiple functions and novel nuclear localization Brain Res. Bull. 81 2010 211 218
3. C. Brocker, N. Lassen, T. Estey, A. Pappa, M. Cantore, V.V. Orlova, T. Chavakis, K.L. Kavanagh, U. Oppermann, and V. Vasiliou Aldehyde dehydrogenase 7A1 (ALDH7A1) is a novel enzyme involved in cellular defense against hyperosmotic stress J. Biol. Chem. 285 2010 18452 18463
4. V. Vasiliou, A. Bairoch, K.F. Tipton, and D.W. Nebert Eukaryotic aldehyde dehydrogenase (ALDH) genes: human polymorphisms, and recommended nomenclature based on divergent evolution and chromosomal mapping Pharmacogenetics 9 1999 421 434
5. B. Jackson, C. Brocker, D.C. Thompson, W. Black, K. Vasiliou, D.W. Nebert, and V. Vasiliou Update on the aldehyde dehydrogenase gene (ALDH) superfamily Hum. Genomics 5 2011 283 303
6. W. Black, and V. Vasiliou The aldehyde dehydrogenase gene superfamily resource center Hum. Genomics 4 2009 136 142
7. V. Vasiliou, and D.W. Nebert Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family Hum. Genomics 2 2005 138 143
8. G. Duester Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid Eur. J. Biochem. 267 2000 4315 4324
9. D. Stagos, Y. Chen, C. Brocker, E. Donald, B.C. Jackson, D.J. Orlicky, D.C. Thompson, and V. Vasiliou Aldehyde dehydrogenase 1B1: molecular cloning and characterization of a novel mitochondrial acetaldehyde-metabolizing enzyme Drug Metab. Dispos. 38 2010 1679 1687
10. Y. Chen, D.J. Orlicky, A. Matsumoto, S. Singh, D.C. Thompson, and V. Vasiliou Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer Biochem. Biophys. Res. Commun. 405 2011 173 179
11. Y. Tsybovsky, and S.A. Krupenko Conserved catalytic residues of the ALDH1L1 aldehyde dehydrogenase domain control binding and discharging of the coenzyme J. Biol. Chem. 286 2011 23357 23367
12. K.C. Strickland, N.I. Krupenko, M.E. Dubard, C.J. Hu, Y. Tsybovsky, and S.A. Krupenko Enzymatic properties of ALDH1L2, a mitochondrial 10-formyltetrahydrofolate dehydrogenase Chem. Biol. Interact. 191 2011 129 136
13. A. Pappa, T. Estey, R. Manzer, D. Brown, and V. Vasiliou Human aldehyde dehydrogenase 3A1 (ALDH3A1): biochemical characterization and immunohistochemical localization in the cornea Biochem. J. 376 2003 615 623
14. W.B. Rizzo, E. Heinz, M. Simon, and D.A. Craft Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjogren-Larsson syndrome Biochim. Biophys. Acta 1535 2000 1 9
15. S.A. Marchitti, C. Brocker, D.J. Orlicky, and V. Vasiliou Molecular characterization, expression analysis, and role of ALDH3B1 in the cellular protection against oxidative stress Free Radic. Biol. Med. 49 2010 1432 1443
16. C.M. Forte-McRobbie, and R. Pietruszko Purification and characterization of human liver "high Km" aldehyde dehydrogenase and its identification as glutamic gamma-semialdehyde dehydrogenase J. Biol. Chem. 261 1986 2154 2163
17. Y.G. Kim, S. Lee, O.S. Kwon, S.Y. Park, S.J. Lee, B.J. Park, and K.J. Kim Redox-switch modulation of human SSADH by dynamic catalytic loop EMBO J. 28 2009 959 968
18. K.L. Chambliss, R.G. Gray, G. Rylance, R.J. Pollitt, and K.M. Gibson Molecular characterization of methylmalonate semialdehyde dehydrogenase deficiency J. Inherit. Metab. Dis. 23 2000 497 504
19. P.B. Mills, E. Struys, C. Jakobs, B. Plecko, P. Baxter, M. Baumgartner, M.A. Willemsen, H. Omran, U. Tacke, B. Uhlenberg, B. Weschke, and P.T. Clayton Mutations in antiquitin in individuals with pyridoxine-dependent seizures Nat. Med. 12 2006 307 309
20. M. Lin, M. Zhang, M. Abraham, S.M. Smith, and J.L. Napoli Mouse retinal dehydrogenase 4 (RALDH4), molecular cloning, cellular expression, and activity in 9-cis-retinoic acid biosynthesis in intact cells J. Biol. Chem. 278 2003 9856 9861
21. A. Sima, M. Parisotto, S. Mader, and P.V. Bhat Kinetic characterization of recombinant mouse retinal dehydrogenase types 3 and 4 for retinal substrates Biochim. Biophys. Acta 1790 2009 1660 1664
22. S.W. Lin, J.C. Chen, L.C. Hsu, C.L. Hsieh, and A. Yoshida Human gamma-aminobutyraldehyde dehydrogenase (ALDH9): cDNA sequence, genomic organization, polymorphism, chromosomal localization, and tissue expression Genomics 34 1996 376 380
23. V. Vasiliou, M. Sandoval, D.S. Backos, B.S. Jackson, Y. Chen, R. Reigan, M.A. Lanaspa, J. Richard, R.J. Johnson, V. Koppaka, D.C. Thompson, ALDH16A1 is a novel protein that may be involved in the etiology of gout via protein-protein interactions with HPRT1, this issue.
24. F. Valverde, M. Losada, and A. Serrano Engineering a central metabolic pathway: glycolysis with no net phosphorylation in an Escherichia coli gap mutant complemented with a plant GapN gene FEBS Lett. 449 1999 153 158
25. C. Brocker, M. Vasiliou, S. Carpenter, C. Carpenter, Y. Zhang, X. Wang, S.O. Kotchoni, A.J. Wood, H.H. Kirch, D. Kopecny, D.W. Nebert, and V. Vasiliou Aldehyde dehydrogenase (ALDH) superfamily in plants: gene nomenclature and comparative genomics Planta 2012
26. J. Samuelson, W.W. Zhang, A. Kumar, S. Descoteaux, P.S. Shen, and G. Bailey Primary structures of alcohol and aldehyde dehydrogenase genes of Entamoeba histolytica Arch. Med. Res. 23 1992 31 33
27. N.A. Sophos, and V. Vasiliou Aldehyde dehydrogenase gene superfamily: the 2002 update Chem. Biol. Interact. 143-144 2003 5 22
28. E.E. Blatter, D.P. Abriola, and R. Pietruszko Aldehyde dehydrogenase. Covalent intermediate in aldehyde dehydrogenation and ester hydrolysis Biochem. J. 282 Pt 2 1992 353 360
29. Z. Chen, J. Zhang, and J.S. Stamler Identification of the enzymatic mechanism of nitroglycerin bioactivation Proc. Natl. Acad. Sci. U S A 99 2002 8306 8311
30. J. Piatigorsky, and G.J. Wistow Enzyme/crystallins: gene sharing as an evolutionary strategy Cell 57 1989 197 199
31. J. Horwitz, L. Ding, V. Vasiliou, M. Cantore, and J. Piatigorsky Scallop lens Omega-crystallin (ALDH1A9): a novel tetrameric aldehyde dehydrogenase Biochem. Biophys. Res. Commun. 348 2006 1302 1309
32. R.D. Zinovieva, S.I. Tomarev, and J. Piatigorsky Aldehyde dehydrogenase-derived omega-crystallins of squid and octopus. Specialization for lens expression J. Biol. Chem. 268 1993 11449 11455
33. G. King, and R. Holmes Human corneal and lens aldehyde dehydrogenases. Purification and properties of human lens ALDH1 and differential expression as major soluble proteins in human lens (ALDH1) and cornea (ALDH3) Adv. Exp. Med. Biol. 414 1997 19 27
34. J.V. Jester, T. Moller-Pedersen, J. Huang, C.M. Sax, W.T. Kays, H.D. Cavangh, W.M. Petroll, and J. Piatigorsky The cellular basis of corneal transparency: evidence for 'corneal crystallins' J. Cell Sci. 112 Pt. 5 1999 613 622
35. T. Estey, J. Piatigorsky, N. Lassen, and V. Vasiliou ALDH3A1: a corneal crystallin with diverse functions Exp. Eye Res. 84 2007 3 12
36. J.V. Jester Corneal crystallins and the development of cellular transparency Semin. Cell Dev. Biol. 19 2008 82 93
37. S.A. Marchitti, Y. Chen, D.C. Thompson, and V. Vasiliou Ultraviolet radiation: cellular antioxidant response and the role of ocular aldehyde dehydrogenase enzymes Eye Contact Lens 37 2011 206 213
38. N. Lassen, A. Pappa, W.J. Black, J.V. Jester, B.J. Day, E. Min, and V. Vasiliou Antioxidant function of corneal ALDH3A1 in cultured stromal fibroblasts Free Radic. Biol. Med. 41 2006 1459 1469
39. Y. Chen, V. Koppaka, D.C. Thompson, and V. Vasiliou Focus on molecules: ALDH1A1: from lens and corneal crystallin to stem cell marker Exp. Eye Res. 2011
40. J.M. Mason, and K.M. Arndt Coiled coil domains: stability, specificity, and biological implications Chembiochem: Eur. J. Chem. Biol. 5 2004 170 176
41. M.C. Hanna, and C. Blackstone Interaction of the SPG21 protein ACP33/maspardin with the aldehyde dehydrogenase ALDH16A1 Neurogenetics 10 2009 217 228
42. R.J. Alexander, B. Silverman, and W.L. Henley Isolation and characterization of BCP 54, the major soluble protein of bovine cornea Exp. Eye Res. 32 1981 205 216
43. A. Pappa, N.A. Sophos, and V. Vasiliou Corneal and stomach expression of aldehyde dehydrogenases: from fish to mammals Chem. Biol. Interact. 130-132 2001 181 191
44. G. Wistow, and H. Kim Lens protein expression in mammals: taxon-specificity and the recruitment of crystallins J. Mol. Evol. 32 1991 262 269
45. N. Lassen, J.B. Bateman, T. Estey, J.R. Kuszak, D.W. Nees, J. Piatigorsky, G. Duester, B.J. Day, J. Huang, L.M. Hines, and V. Vasiliou Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice J. Biol. Chem. 282 2007 25668 25676
46. R. Manzer, L. Qamar, T. Estey, A. Pappa, D.R. Petersen, and V. Vasiliou Molecular cloning and baculovirus expression of the rabbit corneal aldehyde dehydrogenase (ALDH1A1) cDNA DNA Cell Biol. 22 2003 329 338
47. N. Lassen, W.J. Black, T. Estey, and V. Vasiliou The role of corneal crystallins in the cellular defense mechanisms against oxidative stress Semin. Cell Dev. Biol. 19 2008 100 112
48. A. Pappa, C. Chen, Y. Koutalos, A.J. Townsend, and V. Vasiliou Aldh3a1 protects human corneal epithelial cells from ultraviolet- and 4-hydroxy-2-nonenal-induced oxidative damage Free Radic. Biol. Med. 34 2003 1178 1189
49. T. Estey, M. Cantore, P.A. Weston, J.F. Carpenter, J.M. Petrash, and V. Vasiliou Mechanisms involved in the protection of UV-induced protein inactivation by the corneal crystallin ALDH3A1 J. Biol. Chem. 282 2007 4382 4392
50. H. Bloemendal, W. de Jong, R. Jaenicke, N.H. Lubsen, C. Slingsby, and A. Tardieu Ageing and vision: structure, stability and function of lens crystallins Prog. Biophys. Mol. Biol. 86 2004 407 485
51. T. Estey, Y. Chen, J.F. Carpenter, and V. Vasiliou Structural and functional modifications of corneal crystallin ALDH3A1 by UVB light PLoS One 5 2010 e15218
52. J.V. Jester, A. Budge, S. Fisher, and J. Huang Corneal keratocytes: phenotypic and species differences in abundant protein expression and in vitro light-scattering Invest. Ophthalmol. Vis. Sci. 46 2005 2369 2378
53. P. Pappas, P. Stephanou, V. Vasiliou, P. Karamanakos, and M. Marselos Ontogenesis and expression of ALDH activity in the skin and the eye of the rat Adv. Exp. Med. Biol. 414 1997 73 80
54. J. Davis, D. Davis, B. Norman, and J. Piatigorsky Gene expression of the mouse corneal crystallin Aldh3a1: activation by Pax6, Oct1, and p300 Invest. Ophthalmol. Vis. Sci. 49 2008 1814 1826
55. A. Pappa, D. Brown, Y. Koutalos, J. DeGregori, C. White, and V. Vasiliou Human aldehyde dehydrogenase 3A1 inhibits proliferation and promotes survival of human corneal epithelial cells J. Biol. Chem. 280 2005 27998 28006
56. J.V. Jester, D. Brown, A. Pappa, and V. Vasiliou Myofibroblast differentiation modulates keratocyte crystallin protein expression, concentration, and cellular light scattering Invest. Ophthalmol. Vis. Sci. 53 2012 770 778
57. O. Ziouzenkova, G. Orasanu, M. Sharlach, T.E. Akiyama, J.P. Berger, J. Viereck, J.A. Hamilton, G. Tang, G.G. Dolnikowski, S. Vogel, G. Duester, and J. Plutzky Retinaldehyde represses adipogenesis and diet-induced obesity Nat. Med. 13 2007 695 702
58. F.W. Kiefer, G. Orasanu, S. Nallamshetty, J.D. Brown, H. Wang, P. Luger, N.R. Qi, C.F. Burant, G. Duester, and J. Plutzky Retinaldehyde dehydrogenase 1 coordinates hepatic gluconeogenesis and lipid metabolism Endocrinology 153 2012 3089 3099
59. F.W. Kiefer, C. Vernochet, P. O'Brien, S. Spoerl, J.D. Brown, S. Nallamshetty, M. Zeyda, T.M. Stulnig, D.E. Cohen, C.R. Kahn, and J. Plutzky Retinaldehyde dehydrogenase 1 regulates a thermogenic program in white adipose tissue Nat. Med. 2012
60. K. Niederreither, V. Subbarayan, P. Dolle, and P. Chambon Embryonic retinoic acid synthesis is essential for early mouse post-implantation development Nat. Genet. 21 1999 444 448
61. K.L. Deak, M.E. Dickerson, E. Linney, D.S. Enterline, T.M. George, E.C. Melvin, F.L. Graham, D.G. Siegel, P. Hammock, L. Mehltretter, A.G. Bassuk, J.A. Kessler, J.R. Gilbert, and M.C. Speer Analysis of ALDH1A2, CYP26A1, CYP26B1, CRABP1, and CRABP2 in human neural tube defects suggests a possible association with alleles in ALDH1A2, Birth defects research. Part A Clin. Mol. Teratol. 73 2005 868 875
62. M. Pavan, V.F. Ruiz, F.A. Silva, T.J. Sobreira, R.M. Cravo, M. Vasconcelos, L.P. Marques, S.M. Mesquita, J.E. Krieger, A.A. Lopes, P.S. Oliveira, A.C. Pereira, and J. Xavier-Neto ALDH1A2 (RALDH2) genetic variation in human congenital heart disease BMC Med. Genet. 10 2009 113
63. V. Dupe, N. Matt, J.M. Garnier, P. Chambon, M. Mark, and N.B. Ghyselinck A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment Proc. Natl. Acad. Sci. U S A 100 2003 14036 14041
64. L.L. Husemoen, M. Fenger, N. Friedrich, J.S. Tolstrup, S. Beenfeldt Fredriksen, and A. Linneberg The association of ADH and ALDH gene variants with alcohol drinking habits and cardiovascular disease risk factors Alcohol. Clin. Exp. Res. 32 2008 1984 1991
65. A. Linneberg, A. Gonzalez-Quintela, C. Vidal, T. Jorgensen, M. Fenger, T. Hansen, O. Pedersen, and L.L. Husemoen Genetic determinants of both ethanol and acetaldehyde metabolism influence alcohol hypersensitivity and drinking behaviour among Scandinavians Clin. Exp. Allergy 40 2010 123 130
66. J. Palmfeldt, S. Vang, V. Stenbroen, E. Pavlou, M. Baycheva, G. Buchal, A.A. Monavari, P. Augoustides-Savvopoulou, H. Mandel, and N. Gregersen Proteomics reveals that redox regulation is disrupted in patients with ethylmalonic encephalopathy J. Proteome Res. 10 2011 2389 2396
67. O.M. Palo, P. Soronen, K. Silander, T. Varilo, K. Tuononen, T. Kieseppa, T. Partonen, J. Lonnqvist, T. Paunio, and L. Peltonen Identification of susceptibility loci at 7q31 and 9p13 for bipolar disorder in an isolated population American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 153B 2010 723 735
68. R.J. Cook, K.M. Champion, and C.S. Giometti Methanol toxicity and formate oxidation in NEUT2 mice Arch. Biochem. Biophys. 393 2001 192 198
69. K.M. Champion, R.J. Cook, S.L. Tollaksen, and C.S. Giometti Identification of a heritable deficiency of the folate-dependent enzyme 10-formyltetrahydrofolate dehydrogenase in mice Proc. Natl. Acad. Sci. U S A 91 1994 11338 11342
70. S.A. Jo, E.K. Kim, M.H. Park, C. Han, H.Y. Park, Y. Jang, B.J. Song, and I. Jo A Glu487Lys polymorphism in the gene for mitochondrial aldehyde dehydrogenase 2 is associated with myocardial infarction in elderly Korean men Clin. Chim. Acta 382 2007 43 47
71. P. Hui, T. Nakayama, A. Morita, N. Sato, M. Hishiki, K. Saito, Y. Yoshikawa, M. Tamura, I. Sato, T. Takahashi, M. Soma, Y. Izumi, Y. Ozawa, and Z. Cheng Common single nucleotide polymorphisms in Japanese patients with essential hypertension: aldehyde dehydrogenase 2 gene as a risk factor independent of alcohol consumption Hypertens Res. 30 2007 585 592
72. Y.C. Chao, S.R. Liou, Y.Y. Chung, H.S. Tang, C.T. Hsu, T.K. Li, and S.J. Yin Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients Hepatology 19 1994 360 366
73. K. Kamino, K. Nagasaka, M. Imagawa, H. Yamamoto, H. Yoneda, A. Ueki, S. Kitamura, K. Namekata, T. Miki, and S. Ohta Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population Biochem. Biophys. Res. Commun. 273 2000 192 196
74. V. De Laurenzi, G.R. Rogers, D.J. Hamrock, L.N. Marekov, P.M. Steinert, J.G. Compton, N. Markova, and W.B. Rizzo Sjogren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene Nat. Genet. 12 1996 52 57
75. V. Vasiliou, and A. Pappa Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease Pharmacology 61 2000 192 198
76. J.O. Sass, M. Walter, J.P. Shield, A.M. Atherton, U. Garg, D. Scott, C.G. Woods, and L.D. Smith 3-Hydroxyisobutyrate aciduria and mutations in the ALDH6A1 gene coding for methylmalonate semialdehyde dehydrogenase J. Inherit. Metab. Dis. 35 2012 437 442
77. Y. Guo, L.J. Tan, S.F. Lei, T.L. Yang, X.D. Chen, F. Zhang, Y. Chen, F. Pan, H. Yan, X. Liu, Q. Tian, Z.X. Zhang, Q. Zhou, C. Qiu, S.S. Dong, X.H. Xu, Y.F. Guo, X.Z. Zhu, S.L. Liu, X.L. Wang, X. Li, Y. Luo, L.S. Zhang, M. Li, J.T. Wang, T. Wen, B. Drees, J. Hamilton, C.J. Papasian, R.R. Recker, X.P. Song, J. Cheng, and H.W. Deng Genome-wide association study identifies ALDH7A1 as a novel susceptibility gene for osteoporosis PLoS Genet. 6 2010 e1000806
78. P. Sulem, D.F. Gudbjartsson, G.B. Walters, H.T. Helgadottir, A. Helgason, S.A. Gudjonsson, C. Zanon, S. Besenbacher, G. Bjornsdottir, O.T. Magnusson, G. Magnusson, E. Hjartarson, J. Saemundsdottir, A. Gylfason, A. Jonasdottir, H. Holm, A. Karason, T. Rafnar, H. Stefansson, O.A. Andreassen, J.H. Pedersen, A.I. Pack, M.C. de Visser, L.A. Kiemeney, A.J. Geirsson, G.I. Eyjolfsson, I. Olafsson, A. Kong, G. Masson, H. Jonsson, U. Thorsteinsdottir, I. Jonsdottir, and K. Stefansson Identification of low-frequency variants associated with gout and serum uric acid levels Nat. Genet. 43 2011 1127 1130
79. V. Vasiliou, M. Malamas, and M. Marselos The mechanism of alcohol intolerance produced by various therapeutic agents Acta Pharmacol. Toxicol. (Copenh.) 58 1986 305 310
80. M.B. Kastan, E. Schlaffer, J.E. Russo, O.M. Colvin, C.I. Civin, and J. Hilton Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells Blood 75 1990 1947 1950
81. E.C. Forsberg, S.S. Prohaska, S. Katzman, G.C. Heffner, J.M. Stuart, and I.L. Weissman Differential expression of novel potential regulators in hematopoietic stem cells PLoS Genet. 1 2005 e28
82. P. Fallon, T. Gentry, A.E. Balber, D. Boulware, W.E. Janssen, R. Smilee, R.W. Storms, and C. Smith Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation Br. J. Haematol. 122 2003 99 108
83. D.A. Hess, T.E. Meyerrose, L. Wirthlin, T.P. Craft, P.E. Herrbrich, M.H. Creer, and J.A. Nolta Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity Blood 104 2004 1648 1655
84. G.G. Muramoto, J.L. Russell, R. Safi, A.B. Salter, H.A. Himburg, P. Daher, S.K. Meadows, P. Doan, R.W. Storms, N.J. Chao, D.P. McDonnell, and J.P. Chute Inhibition of aldehyde dehydrogenase expands hematopoietic stem cells with radioprotective capacity Stem Cells 28 2010 523 534
85. D.A. Hess, L. Wirthlin, T.P. Craft, P.E. Herrbrich, S.A. Hohm, R. Lahey, W.C. Eades, M.H. Creer, and J.A. Nolta Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells Blood 107 2006 2162 2169
86. M. Lioznov, C. Dellbrugger, A. Sputtek, B. Fehse, N. Kroger, and A.R. Zander Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM Bone Marrow Transplant. 42 2008 121 128
87. M.V. Lioznov, P. Freiberger, N. Kroger, A.R. Zander, and B. Fehse Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants Bone Marrow Transplant. 35 2005 909 914
88. A.M. Cheung, T.S. Wan, J.C. Leung, L.Y. Chan, H. Huang, Y.L. Kwong, R. Liang, and A.Y. Leung Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential Leukemia 21 2007 1423 1430
89. D. Ran, M. Schubert, L. Pietsch, I. Taubert, P. Wuchter, V. Eckstein, T. Bruckner, M. Zoeller, and A.D. Ho Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes Exp. Hematol. 37 2009 1423 1434
90. J.M. Gerber, B.D. Smith, B. Ngwang, H. Zhang, M.S. Vala, L. Morsberger, S. Galkin, M.I. Collector, B. Perkins, M.J. Levis, C.A. Griffin, S.J. Sharkis, M.J. Borowitz, J.E. Karp, and R.J. Jones A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia Blood 119 2012 3571 3577
91. M. Gasparetto, S. Sekulovic, A. Zakaryan, S. Imren, D.G. Kent, R.K. Humphries, V. Vasiliou, and C. Smith Varying levels of aldehyde dehydrogenase activity in adult murine marrow hematopoietic stem cells are associated with engraftment and cell cycle status Exp. Hematol. 2012
92. M. Gasparetto, S. Sekulovic, C. Brocker, P. Tang, A. Zakaryan, P. Xiang, F. Kuchenbauer, M. Wen, K. Kasaian, M.F. Witty, P. Rosten, Y. Chen, S. Imren, G. Duester, D.C. Thompson, R.K. Humphries, V. Vasiliou, and C. Smith Aldehyde dehydrogenases are regulators of hematopoietic stem cell numbers and B-cell development Exp. Hematol. 40 2012 318 329 e312
93. B.P. Levi, O.H. Yilmaz, G. Duester, and S.J. Morrison Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems Blood 113 2009 1670 1680
94. J.P. Chute, G.G. Muramoto, J. Whitesides, M. Colvin, R. Safi, N.J. Chao, and D.P. McDonnell Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells Proc. Natl. Acad. Sci. U S A 103 2006 11707 11712
95. A.C.H. Ma, M.I.S. Chung, R. Liang, and A.Y.H. Leung A DEAB-sensitive aldehyde dehydrogenase regulates hematopoietic stem and progenitor cells development during primitive hematopoiesis in zebrafish embryos Leukemia 2010
96. M.F. Clarke, J.E. Dick, P.B. Dirks, C.J. Eaves, C.H. Jamieson, D.L. Jones, J. Visvader, I.L. Weissman, and G.M. Wahl Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells Cancer Res. 66 2006 9339 9344
97. W.J. Mackillop, A. Ciampi, J.E. Till, and R.N. Buick A stem cell model of human tumor growth: implications for tumor cell clonogenic assays J. Natl. Cancer Inst. 70 1983 9 16
98. T. Reya, S.J. Morrison, M.F. Clarke, and I.L. Weissman Stem cells, cancer, and cancer stem cells Nature 414 2001 105 111
99. A. Soltysova, V. Altanerova, and C. Altaner Cancer stem cells Neoplasma 52 2005 435 440
100. M. Todaro, F. Iovino, V. Eterno, P. Cammareri, G. Gambara, V. Espina, G. Gulotta, F. Dieli, S. Giordano, R. De Maria, and G. Stassi Tumorigenic and metastatic activity of human thyroid cancer stem cells Cancer Res. 70 2010 8874 8885
101. D. Ucar, C.R. Cogle, J.R. Zucali, B. Ostmark, E.W. Scott, R. Zori, B.A. Gray, and J.S. Moreb Aldehyde dehydrogenase activity as a functional marker for lung cancer Chem. Biol. Interact. 178 2009 48 55
102. F. Jiang, Q. Qiu, A. Khanna, N.W. Todd, J. Deepak, L. Xing, H. Wang, Z. Liu, Y. Su, S.A. Stass, and R.L. Katz Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer Mol. Cancer Res. 7 2009 330 338
103. C. van den Hoogen, G. van der Horst, H. Cheung, J.T. Buijs, J.M. Lippitt, N. Guzman-Ramirez, F.C. Hamdy, C.L. Eaton, G.N. Thalmann, M.G. Cecchini, R.C. Pelger, and G. van der Pluijm High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer Cancer Res. 70 2010 5163 5173
104. Z.A. Rasheed, J. Yang, Q. Wang, J. Kowalski, I. Freed, C. Murter, S.M. Hong, J.B. Koorstra, N.V. Rajeshkumar, X. He, M. Goggins, C. Iacobuzio-Donahue, D.M. Berman, D. Laheru, A. Jimeno, M. Hidalgo, A. Maitra, and W. Matsui Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma J. Natl. Cancer Inst. 102 2010 340 351
105. L. Wang, P. Park, H. Zhang, F. La Marca, and C.Y. Lin Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity Int. J. Cancer 2010
106. M.R. Clay, M. Tabor, J.H. Owen, T.E. Carey, C.R. Bradford, G.T. Wolf, M.S. Wicha, and M.E. Prince Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase Head Neck 2010
107. A.K. Croker, D. Goodale, J. Chu, C. Postenka, B.D. Hedley, D.A. Hess, and A.L. Allan High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability J. Cell Mol. Med. 13 2009 2236 2252
108. C. Ginestier, M.H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, M. Brown, J. Jacquemier, P. Viens, C.G. Kleer, S. Liu, A. Schott, D. Hayes, D. Birnbaum, M.S. Wicha, and G. Dontu ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 2007 555 567
109. J.E. Carpentino, M.J. Hynes, H.D. Appelman, T. Zheng, D.A. Steindler, E.W. Scott, and E.H. Huang Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer Cancer Res. 69 2009 8208 8215
110. E.H. Huang, M.J. Hynes, T. Zhang, C. Ginestier, G. Dontu, H. Appelman, J.Z. Fields, M.S. Wicha, and B.M. Boman Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis Cancer Res. 69 2009 3382 3389
111. E. Charafe-Jauffret, C. Ginestier, F. Iovino, C. Tarpin, M. Diebel, B. Esterni, G. Houvenaeghel, J.M. Extra, F. Bertucci, J. Jacquemier, L. Xerri, G. Dontu, G. Stassi, Y. Xiao, S.H. Barsky, D. Birnbaum, P. Viens, and M.S. Wicha Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer Clin. Cancer Res. 16 2009 45 55
112. S.J. Dylla, L. Beviglia, I.K. Park, C. Chartier, J. Raval, L. Ngan, K. Pickell, J. Aguilar, S. Lazetic, S. Smith-Berdan, M.F. Clarke, T. Hoey, J. Lewicki, and A.L. Gurney Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy PLoS One 3 2008 e2428
113. I.A. Silva, S. Bai, K. McLean, K. Yang, K. Griffith, D. Thomas, C. Ginestier, C. Johnston, A. Kueck, R.K. Reynolds, M.S. Wicha, and R.J. Buckanovich Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival Cancer Res. 71 2011 3991 4001
114. J.B. Boonyaratanakornkit, L. Yue, L.R. Strachan, K.J. Scalapino, P.E. LeBoit, Y. Lu, S.P. Leong, J.E. Smith, and R. Ghadially Selection of tumorigenic melanoma cells using ALDH J. Invest. Dermatol. 130 2010 2799 2808
115. Y. Luo, K. Dallaglio, Y. Chen, W.A. Robinson, S.E. Robinson, M.D. McCarter, J. Wng, R. Gozalez, D.C. Thompson, D.A. Norris, D.R. Roop, V. Vasiliou, and M. Fujita ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets Stem Cells 30 2012 2100 2113
116. P.E. Burger, R. Gupta, X. Xiong, C.S. Ontiveros, S.N. Salm, D. Moscatelli, and E.L. Wilson High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells Stem Cells 27 2009 2220 2228
117. E. Resetkova, J.S. Reis-Filho, R.K. Jain, R. Mehta, M.A. Thorat, H. Nakshatri, and S. Badve Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment Breast Cancer Res. Treat 123 2009 97 108
118. E. Charafe-Jauffret, C. Ginestier, F. Iovino, C. Tarpin, M. Diebel, B. Esterni, G. Houvenaeghel, J.M. Extra, F. Bertucci, J. Jacquemier, L. Xerri, G. Dontu, G. Stassi, Y. Xiao, S.H. Barsky, D. Birnbaum, P. Viens, and M.S. Wicha Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer Clin. Cancer Res. 16 2010 45 55
119. V. Neumeister, S. Agarwal, J. Bordeaux, R.L. Camp, and D.L. Rimm In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis Am. J. Pathol. 176 2010 2131 2138
120. P. Marcato, C.A. Dean, D. Pan, R. Araslanova, M. Gillis, M. Joshi, L. Helyer, L. Pan, A. Leidal, S. Gujar, C.A. Giacomantonio, and P.W. Lee Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis Stem Cells 29 2011 32 45
121. B. Chang, G. Liu, F. Xue, D.G. Rosen, L. Xiao, X. Wang, and J. Liu ALDH1 expression correlates with favorable prognosis in ovarian cancers Mod. Pathol. 22 2009 817 823
122. S. Deng, X. Yang, H. Lassus, S. Liang, S. Kaur, Q. Ye, C. Li, L.P. Wang, K.F. Roby, S. Orsulic, D.C. Connolly, Y. Zhang, K. Montone, R. Butzow, G. Coukos, and L. Zhang Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers PLoS One 5 2010 e10277
123. T. Li, Y. Su, Y. Mei, Q. Leng, B. Leng, Z. Liu, S.A. Stass, and F. Jiang ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome Lab. Invest. 90 2010 234 244
124. S.A. Marchitti, D.J. Orlicky, C. Brocker, and V. Vasiliou Aldehyde dehydrogenase 3B1 (ALDH3B1): immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissues J. Histochem. Cytochem. 58 2010 765 783
125. M. Patel, L. Lu, D.S. Zander, L. Sreerama, D. Coco, and J.S. Moreb ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors Lung Cancer 59 2008 340 349
126. M. Leid, P. Kastner, and P. Chambon Multiplicity generates diversity in the retinoic acid signalling pathways Trends Biochem. Sci. 17 1992 427 433
127. J.E. Balmer, and R. Blomhoff A robust characterization of retinoic acid response elements based on a comparison of sites in three species J. Steroid. Biochem. Mol. Biol. 96 2005 347 354
128. C.T. Jordan, M.L. Guzman, and M. Noble Cancer stem cells N. Engl. J. Med. 355 2006 1253 1261
129. M. Khanna, C.H. Chen, A. Kimble-Hill, B. Parajuli, S. Perez-Miller, S. Baskaran, J. Kim, K. Dria, V. Vasiliou, D. Mochly-Rosen, and T.D. Hurley Discovery of a novel class of covalent inhibitor for aldehyde dehydrogenases J. Biol. Chem. 286 2011 43486 43494
130. V. Koppaka, D.C. Thompson, Y. Chen, M. Ellermann, K.C. Nicolaou, R.O. Juvonen, D. Petersen, R.A. Deitrich, T.D. Hurley, and V. Vasiliou Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application Pharmacol. Rev. 2012